MapmyGenome Brings Down Cost of Genetic Testing Dramatically with Sugargene™
Hyderabad, India — November 28, 2014: MapmyGenome launched Sugargene™ on November 27, 2014 — a new affordable personal genomics test designed to help Indians understand their genetic risk of type 2 diabetes and obesity, their nutrigenetics profile, and personalised management options.
“Most of us have at least one person in the family suffering from diabetes and have seen how it painfully attacks the rest of the body. Diabetes is preventable but intervention must be done early. We listened to our customers and ensured that Sugargene is affordable for all — providing both fun facts and a plan to work towards a healthier life. We aim to combat two of the greatest global epidemics of our time: Obesity and Type 2 Diabetes.” — Anu Acharya, CEO, MapmyGenome
What Does Sugargene™ Test?
Genetic predisposition to type 2 diabetes and obesity
Nutrigenetics traits — satiety levels, sugar cravings, carbohydrate and fat metabolism
Prevention and treatment options personalised to your DNA
About MapmyGenome
MapmyGenome is a molecular diagnostics company for people who are proactive about their health. Their personal genomics portfolio includes Genomepatri™, Cardiomap™, Oncomap™, and genetic counselling services.
Know Your Diabetes & Obesity Risk Genetically
Genomepatri by MapmyGenome gives you a comprehensive metabolic and nutritional genetic profile — covering type 2 diabetes risk, obesity predisposition, sugar metabolism, and more — so you can take preventive action before diabetes takes hold.
